How a new AI tool may predict the early signs of Parkinson’s The technology has helped to identify potential markers in the blood of people who later developed the disease.
‘Alarming’ shortfall in aged care COVID vaccination GPs are being urged to help increase rates ahead of winter, with around three quarters of eligible residents yet to receive a booster.
Shingrix to replace Zostavax on the National Immunisation Program The news has been welcomed by the Immunisation Coalition, but there are also concerns about eligibility restrictions.
Most antidepressants used for chronic pain lack evidence: Study The effectiveness and safety of many drugs commonly prescribed for chronic pain is not known, a Cochrane Review has found.
First RSV vaccine approved in US The US drugs regulator has given the green light to a new vaccine, which is also under consideration by the TGA in Australia.
Australian-first study reveals full scope of GP skin cancer care Researchers hope the findings will help guide education, policy and interventions to optimise skin cancer prevention and management.
GP considerations when prescribing medicinal cannabis SPONSORED: Medicinal cannabis prescription rates are increasing – what does the latest research say about its safety?
New overdose report a ‘wake-up call’ Nearly 1800 drug-induced deaths were recorded in 2021 – equivalent to five per day – a new UNSW report has found.
An ageing population and a GP workforce shortage: Is team-based care the answer? newsGP speaks with a general practice where multidisciplinary care is the cornerstone of serving the needs of an increasingly complex patient cohort.
PBAC to review FP 50 decision Controls placed on GPs initiating PBS prescriptions of the commonly used paediatric asthma medicine will be revisited at the next intracycle meeting.